Literature DB >> 15635173

Pharmacological properties of traditional medicine (XXX): effects of Gyokuheifusan ([Symbol: see text]) on murine antigen-specific antibody production.

Toshiaki Makino1, Shin-Ya Sasaki, Yoshiaki Ito, Yoshihiro Kano.   

Abstract

In the theory of traditional Chinese medicine (TCM), eqi ([Symbol: see text]) circulates at the superficial portion of the body to guard against exopathogen. Gyokuheifusan (GHS; [Symbol: see text]), containing Astragalus Root, Atractylodes Rhizome, and Saposhnikovia Root, is a TCM formula to treat the insufficiency of eqi by invigorating qi and consolidating the superficial resistance. In this study, we evaluated the effect of GHS on murine antibody production against ovalbumin (OVA) used as exopathogen. Balb/c mice were sensitized with OVA and alum via intraperitoneal (i.p.) injection or intranasal (i.n.) infusion daily for 7 d. GHS was orally administered daily at the dose of 10-times amount of human daily dosage from 3 d before the sensitization for 14 d. Fourteen d after the final sensitization, the blood was collected, and the concentrations of OVA-specific or non-specific immunoglobulins were measured. When OVA was sensitized i.p., the concentration of OVA-specific IgG, IgG1, IgG2a and IgA in the sera significantly increased by GHS-treatment. When OVA was sensitized i.n., GHS significantly reduce the concentration of OVA-specific IgG and IgG1 in the sera. Non-specific immunoglobulins were not changed by GHS-treatment. It is suggested that GHS could stimulate immune responses when antigen had already been invaded into the inside of the body, and that GHS might consolidate the resistance of nasal mucosa to protect from the invasion of OVA, then OVA-specific antibodies in sera might be hypocritically suppressed. The present study might provide the experimental evidence for TCM theory.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15635173     DOI: 10.1248/bpb.28.110

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  8 in total

Review 1.  Modified Yupingfeng formula for the treatment of stable chronic obstructive pulmonary disease: a systematic review of randomized controlled trials.

Authors:  Yunqing Zhong; Xiufeng Wang; Guanglan Xu; Bing Mao; Wei Zhou; Jie Min; Hongli Jiang; Xiang Diao; Juanjuan Fu
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-11-02

2.  Anti-inflammatory and immunoregulatory effects of Yupingfeng powder on chronic bronchitis rats.

Authors:  Jue Song; Jun Li; Shi-Rui Zheng; Yong Jin; Yan Huang
Journal:  Chin J Integr Med       Date:  2013-03-15       Impact factor: 1.978

3.  Pharmacokinetic-pharmacodynamic evaluation of the major component astragaloside IV on the immunomodulatory effects of Yu-ping-feng prescription.

Authors:  Jue Song; Jun Li; Yong Jin; Hao Wang; Shirui Zheng; Jian Gao
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-12-18       Impact factor: 2.441

4.  The effects of two Chinese herbal medicinal formulae vs. placebo controls for treatment of allergic rhinitis: a randomised controlled trial.

Authors:  Rose Y P Chan; Wai Tong Chien
Journal:  Trials       Date:  2014-07-02       Impact factor: 2.279

5.  Complementary therapies in allergic rhinitis.

Authors:  Ibrahim Sayin; Cemal Cingi; Fatih Oghan; Bahadir Baykal; Seckin Ulusoy
Journal:  ISRN Allergy       Date:  2013-11-13

6.  Yu Ping Feng San, an ancient Chinese herbal decoction, regulates the expression of inducible nitric oxide synthase and cyclooxygenase-2 and the activity of intestinal alkaline phosphatase in cultures.

Authors:  Crystal Y Q Du; Roy C Y Choi; Tina T X Dong; David T W Lau; Karl W K Tsim
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

Review 7.  Potential effectiveness of Chinese herbal medicine Yu ping feng san for adult allergic rhinitis: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Qiulan Luo; Claire Shuiqing Zhang; Lihong Yang; Anthony Lin Zhang; Xinfeng Guo; Charlie Changli Xue; Chuanjian Lu
Journal:  BMC Complement Altern Med       Date:  2017-11-06       Impact factor: 3.659

8.  Development of an SPE-HPLC-MS method for simultaneous determination and pharmacokinetic study of bioactive constituents of Yu Ping Feng San in rat plasma after oral administration.

Authors:  Tao Li; Yiwei Wang; Yanli Wang; Rixin Liang; Dong Zhang; Huihui Zhang; Li Chen; Weipeng Yang
Journal:  J Ethnopharmacol       Date:  2012-12-20       Impact factor: 4.360

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.